Stock Fundamentals

Company Information

Company Name
GH Research PLC
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: IE000GID8VI0
CIK: 0001855129
Currency: USD
Full Time Employees: 73
Phone: 353 1 437 8334
Fiscal Year End: December
IPO Date: Jun 25, 2021
Description:

GH Research PLC, together with its subsidiary, operates a clinical-stage biopharmaceutical company that develops treatments for depression in the United States. The company's lead product candidate is GH001, an inhalable mebufotenin product candidate that is in Phase 2b clinical trial for treating patients with treatment-resistant depression and in Phase 2a clinical trials for treating bipolar II disorder and postpartum depression. It also develops GH002, an intravenous mebufotenin product candidate, which is in phase 1 clinical pharmacology trial in healthy volunteers focusing on psychiatric and neurological disorders. The company was founded in 2018 and is based in Dublin, Ireland.

Address:

Joshua Dawson House, Dublin, Ireland, D02 RY95

Directors & Officers

Name Title Year Born
Mr. Florian Schonharting M.Sc. (Econ) Co-Founder & Non-Executive Chairman of the Board 1969
Dr. Velichka Valcheva M.D., M.Sc. Chief Executive Officer 1975
Mr. Magnus Halle Co-Founder & MD of Ireland 1997
Ms. Julie Ryan F.C.A. Vice President of Finance 1986
Mr. Aaron Cameron M.B.A. Chief Operating Officer 1985

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Lynx1 Capital Management, LP 10.76M Mar 31, 2026 15.69% $23.92 3.43%
Bvf Inc 8.65M Mar 31, 2026 12.61% $3.87 -2.01%
RA Capital Management, LLC 7.68M Mar 31, 2026 11.19% $1.14 0.00%
RTW INVESTMENTS, LLC 5.93M Mar 31, 2026 8.65% $0.83 0.00%
FMR Inc 5.14M Mar 31, 2026 7.49% $0.00 0.00%
venBio Select Advisor LLC 1.80M Mar 31, 2026 2.62% $0.25 0.00%
The Toronto-Dominion Bank 1.40M Mar 31, 2026 2.04% $0.03 0.00%
Millennium Management LLC 937.90K Mar 31, 2026 1.37% $0.01 216.94%
Jefferies Financial Group Inc 712.30K Mar 31, 2026 1.04% $0.07 0.00%
5AM Venture Management, LLC 572.67K Mar 31, 2026 0.83% $2.24 0.00%
BlackRock Inc 455.62K Mar 31, 2026 0.66% $0.00 4.88%
UBS Group AG 412.42K Mar 31, 2026 0.60% $0.00 13.49%
Squadron Capital Management LLC 325.00K Mar 31, 2026 0.47% $1.67 3.17%
Foresite Capital Management VI LLC 315.49K Mar 31, 2026 0.46% $0.96 0.00%
BOOTHBAY FUND MANAGEMENT, LLC 282.89K Mar 31, 2026 0.41% $0.05 152.17%
CenterBook Partners LP 216.57K Mar 31, 2026 0.32% $0.16 -23.59%
HighVista Strategies LLC 213.21K Mar 31, 2026 0.31% $0.83 -11.36%
Marshall Wace Asset Management Ltd 91.11K Mar 31, 2026 0.13% $0.00 -62.16%
Occam Crest Management L.P. 80.00K Mar 31, 2026 0.12% $0.68 0.00%
Trexquant Investment LP 69.81K Mar 31, 2026 0.10% $0.01 27.44%

Shares Statistics

Shares Outstanding: 68.61M
Shares Float: 26.72M
% Insiders: 2,422.60%
% Institutions: 7,021.90%
Short % Float: 8.19%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Growth Compy Commingled Pl S 2.76M 4.02% ▲ 6.73% Apr 30, 2026
2 Fidelity Growth Company Fund 1.69M 2.46% ▲ 8.43% Apr 30, 2026
3 Fidelity Growth Company K6 561.77K 0.82% ▲ 6.63% Apr 30, 2026
4 Fidelity Series Growth Company 421.70K 0.61% ▲ 11.80% Apr 30, 2026
5 iShares Biotechnology ETF 330.55K 0.48% ▲ 1.95% May 29, 2026
6 AdvisorShares Psychedelics ETF 93.72K 0.14% ▲ 0.00% May 29, 2026
7 Fidelity Select Biotechnology 92.50K 0.13% ▲ 0.00% Apr 30, 2026
8 iShares MSCI Ireland ETF 53.94K 0.08% ▲ 13.81% May 29, 2026
9 iShares Nasdaq US Biotech ETF USD Acc 45.47K 0.07% ▲ 0.00% May 29, 2026
10 Fidelity Nasdaq Composite Index 40.48K 0.06% ▲ 0.00% Apr 30, 2026

Valuation Metrics

Enterprise Value: $1.18B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $1.45B
EBITDA: $-66.58M
Book Value: $4.25
Earnings/Share: $-0.91
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -13.99%
ROE (TTM): -19.67%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 34.13x 0.00x 0.03x -131.05x -0.01x
2024-12-31 17.23x 0.00x 0.05x -70.17x -0.01x
2023-12-31 24.49x 0.00x 0.03x -57.02x -0.01x
2022-12-31 37.07x 0.00x 0.02x -3.77x 0.00x
2021-12-31 101.80x 0.00x 0.01x -1,677.78x 0.00x
2020-12-31 24.03x 0.00x 0.04x N/A 0.00x
2019-12-31 4.85x 0.00x 0.21x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about GHRS.US!